Vimarsana
Biggest News Aggregation in the World

David Telander News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Telander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Telander Today - Breaking & Trending Today

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit - Vimarsana News

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

Published: May 6, 2024

BCVA gains of +5.5 letters at 24 months in Cohort 4 patients BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion Maintenance or increases...

Source: marketscreener.com
Related Topics:
Israel GeneralUnited StatesDavid TelanderBrianm CulleyRoche GroupFoundation Fighting BlindnessExchange CommissionOregon Health Science University Casey Eye InstituteRetinal Consultants Medical GroupEterna Therapeutics IncLineage Cell Therapeutics IncLineage Cell TherapeuticsGene Therapy InnovationOregon HealthScience University Casey EyeRetinal Pigment EpitheliumCell TherapyGeographic AtrophyEarly Treatment Diabetic Retinopathy StudyRetinal CellGene Therapy Innovation SummitOpregen PhaseCell TherapeuticsEterna TherapeuticsAnnual Report
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit - Vimarsana News

RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

Published: March 13, 2024

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that 24 month results from patients enrolled in...

Source: marketscreener.com
Related Topics:
United StatesDavid TelanderLineage Cell Therapeutics IncCasey Eye InstituteRetinal Consultants Medical GroupExchange CommissionEterna Therapeutics IncOregon Health Science University Casey Eye InstituteRoche GroupFoundation Fighting BlindnessLineage Cell TherapeuticsGene Therapy InnovationHyatt Regency SeattleOregon HealthScience University Casey EyeRetinal Pigment EpitheliumCell TherapyGeographic AtrophyRetinal CellGene Therapy Innovation SummitFoundation FightingEye InstitutePacific NorthwestOpregen PhaseCell Therapeutics